AI assistant
Sending…
BECTON DICKINSON & CO — Director's Dealing 2020
Nov 30, 2020
30003_dirs_2020-11-30_1993c12f-0be0-40e9-8216-b3e45ae3212e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2020-11-26
Reporting Person: Kaltenbach Patrick (EVP & Pres Life Sciences)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-26 | Rights to Common Stock Under BD Deferred Compensation Plan | $ | A | 621 | Acquired | Common Stock (621) | Direct |
Footnotes
F1: The securities convert to common stock on a one-for-one basis.
F2: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person.